Matsui, Hiroki
Fushimi, Kiyohide
Yasunaga, Hideo
Funding for this research was provided by:
the JSPS KAKENHI (21H03159)
the Ministry of Health, Labor, and Family Welfare, Japan, (23AA2003 and 24AA2006, 23AA2003 and 24AA2006)
Article History
Received: 9 January 2024
Accepted: 4 April 2025
First Online: 11 April 2025
Declarations
:
: This study conformed to the Declaration of Helsinki and the Japanese ethical guidelines (Ethical Guidelines for Medical and Biological Research Involving Human Subjects). This study was approved by the Ethics Committee of the University of Tokyo School of Medicine (approval number: 3501-(5)). The requirement for written informed consent was waived according to Japanese medical ethics guideline.
: Not applicable.
: HM participated in a joint research project conducted by the University of Tokyo and Pfizer Inc. HM belongs to the Department of Health Service Research at the University of Tokyo, which conducts a socially cooperative course with the Tsumura Corporation. The other authors declare that there are no competing interests.